Share chart Day One Biopharmaceuticals, Inc.
Extended chart
Simple chart
About Day One Biopharmaceuticals, Inc.
Биофармацевтическая компания Day One Biopharmaceuticals, Inc., работающая на клинической стадии, разрабатывает и коммерциализирует таргетные методы лечения пациентов с генетически определенным раком. Его ведущим кандидатом на продукцию является DAY101, пероральный ингибитор быстро ускоряющейся киназы фибросаркомы типа II, проникающий в мозг, который проходит клинические испытания фазы II для педиатрических пациентов с рецидивирующей / прогрессирующей глиомой низкой степени злокачественности. more details| IPO date | 2021-05-27 |
|---|---|
| ISIN | US23954D1090 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | http://dayonebio.com |
| Цена ао | 8.06 |
| Change price per day: | -2.66% (8.28) |
|---|---|
| Change price per week: | -2.66% (8.28) |
| Change price per month: | -33.83% (12.18) |
| Change price per 3 month: | -36.39% (12.67) |
| Change price per half year: | -43.6% (14.29) |
| Change price per year: | -48.96% (15.79) |
| Change price per 3 year: | -24.46% (10.67) |
| Change price per year to date: | -36.78% (12.75) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 6 | 7.36 |
| Blackrock Inc. | 5 | 5.76 |
| Vanguard Group Inc | 5 | 5.46 |
| FMR, LLC | 4 | 5.04 |
| Franklin Resources, Inc. | 4 | 4.36 |
| State Street Corporation | 3 | 3.31 |
| Viking Global Investors, L.P. | 3 | 2.93 |
| Pictet Asset Management Holding SA | 2 | 2.72 |
| Price (T.Rowe) Associates Inc | 2 | 2.63 |
| Braidwell LP | 2 | 2.49 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Future Tech ETF | 0.14317 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 0.14317 | 618.5 | 0.8416 |
| iShares Morningstar Small-Cap Growth ETF | 0.02178 | 572.1 | 0.72598 |
| iShares Morningstar Small-Cap ETF | 0.01885 | 391.25 | 1.60498 |
| iShares Morningstar Small-Cap Value ETF | 0.01569 | 189.23 | 2.50476 |
| 0.07 | 439.48 | 1.3 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Jeremy Bender M.B.A., Ph.D. | CEO, President & Director | 900k | 1971 (54 years) |
| Dr. Samuel C. Blackman M.D., Ph.D. | Co-Founder and Head of R&D | 651k | 1969 (56 years) |
| Dr. Davy Chiodin Ph.D., Pharm.D. | Chief Development Officer | N/A | |
| Ms. Jaa Roberson | Chief People Officer | N/A | |
| Mr. Adam Dubow | General Counsel and Chief Compliance Officer | N/A | 1967 (58 years) |
| Ms. Lauren Merendino M.B.A. | Chief Commercial Officer | N/A | 1976 (49 years) |
| Dr. Elly Barry M.D. | Chief Medical Officer | N/A | |
| Mr. Charles N. York II, M.B.A. | COO, CFO & Secretary | 1977 (48 years) | |
| Mr. John Stubenrauch Ph.D. | Chief Technology Officer |
Address: United States, South San Francisco, CA -, 395 Oyster Point Boulevard - open in Google maps, open in Yandex maps
Website: http://dayonebio.com
Website: http://dayonebio.com
